Developer docs
API playgroundTry for free, no card

Search company profiles

ORFLO Technologies

Full company profile

uuid0002n8z

Namestring
ORFLO Technologies
Legal namestring
Precision Cell Systems, Inc.
Websiteurl
orflo.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

ORFLO Technologies, operating as Precision Cell Systems, Inc., is a privately-held life sciences instrumentation company founded in 2010 and headquartered in Livermore, California (with a listed address in Ketchum, Idaho). The company develops precision laboratory instruments for upstream cell-based workflows, serving genomics laboratories, translational oncology and cell therapy programs (including CAR-T QC), pharmaceutical and contract research organizations, and flow cytometry core facilities. As of the input, the company has 1,000+ instruments installed globally across 700+ institutions, with 200+ peer-reviewed publications citing its technology, and headcount in the 11-50 band.

The product portfolio centers on two complementary platforms: the Singulator family of automated tissue dissociation systems (Singulator 100, Singulator 200, and Singulator 200+) which convert fresh, frozen, or FFPE tissue into sequencing-ready cells or nuclei via software-locked, cold-temperature (4°C), enzyme-free protocols in 6-10 minutes; and the Moxi family of Coulter-principle impedance-based cell counters (Moxi V, Moxi Z for counting and sizing; Moxi GO II for counting combined with two-color fluorescence). The core technology is Coulter-principle impedance measurement, delivering NIST-traceable volumetric cell counting at <2% coefficient of variation with natural debris exclusion — substantially more precise than image-based alternatives (20-30% CV). The Moxi GO II adds 488nm laser fluorescence with dual PMTs and native 21 CFR Part 11 compliance for regulated environments.

The business model combines capital equipment sales (Singulator and Moxi instruments, quote-based pricing via "Request a Quote" and "Talk to a Specialist"), recurring revenue from disposable cassettes and consumables, and supporting application-scientist consultation services (notably a 20-minute workflow evaluation offering). Go-to-market is sales-led, targeting enterprise buyers through direct sales supported by content marketing, peer-reviewed validation assets, a resource library, webinars (Eventbrite, GenomeWeb, GoToWebinar, Zoom), conference engagement, and an e-commerce store for mid-market consumables access. Total disclosed funding to date is approximately $1.36M across two rounds (2013 and 2017), indicating a capital-efficient, largely revenue-funded operating posture. Compliance footprint includes 21 CFR Part 11 on the Moxi GO II, GDPR, and CCPA.

Short descriptiontext

ORFLO Technologies (Precision Cell Systems, Inc.) is a privately-held life sciences instrumentation company that develops automated tissue dissociation systems (Singulator) and Coulter-principle cell counters (Moxi) serving genomics labs, cell therapy programs, pharmaceutical manufacturers, and flow cytometry core facilities worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKetchum, United States
HQ citystring
Ketchum
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell counting instruments, tissue dissociation systems, flow cytometry analyzers, single-cell genomics tools, cell analysis instruments
Industry3 codes
PRIMARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Life Sciences Instrumentation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Precision Instruments (Capital Equipment)
TypeHardware Sales
Description

Sale of automated tissue dissociation systems (Singulator) and cell counters (Moxi family). Instruments include Singulator 100, Singulator 200, Singulator 200+, Moxi V, Moxi Z, and Moxi GO II.

orflo.com
2Disposable Consumables
TypeHardware Sales
Description

Cassette-based system uses disposable cassettes for cell counting. Consumables provide recurring revenue stream and zero-maintenance operation model.

orflo.com
3Professional Services/Application Support
TypeProfessional Services
Description

Application scientist consultations for workflow evaluation, offering 20-minute sessions to assess workflow, tissue types, and relevant validation data.

orflo.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ORFLO Technologies (doing business as Precision Cell Systems) develops and manufactures precision laboratory instruments for cell-based workflows, primarily automated tissue dissociation systems (Singulator family) and Coulter-principle impedance-based cell counters (Moxi family, including fluorescence-capable Moxi GO II). Products are sold to genomics, translational oncology, cell therapy, pharma, and CRO laboratories, supported by disposable cassettes for recurring consumable revenue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 10x more viable cells recovered (96% viability) vs. gentleMACS in peer-reviewed glioblastoma study
+5 more records
Product overview1 text field

ORFLO Technologies (Precision Cell Systems) offers a suite of precision laboratory instruments for cell-based workflows comprising the Singulator family for automated tissue dissociation and the Moxi family for Coulter-principle cell counting. The Singulator product line includes Singulator 100, Singulator 200, and Singulator 200+ models, providing automated conversion of fresh, frozen, or FFPE tissue to sequencing-ready cells with cold-temperature, software-locked processing. The Moxi product line encompasses Moxi V and Moxi Z (impedance-based Coulter-principle cell counters) and Moxi GO II (combining Coulter-principle counting with two-color fluorescence phenotyping). These instruments are designed as upstream precision solutions feeding sequencers and cytometers in genomics, translational oncology, and regulated manufacturing environments.

Product and service7 records
1Singulator 100
CategoryTissue Dissociation Instrument
Description

Entry-level automated tissue dissociation system with software-locked reproducibility for converting fresh, frozen, and FFPE tissue samples to sequencing-ready cells using cold-temperature, enzyme-free processing.

2Singulator 200
CategoryTissue Dissociation Instrument
Description

Mid-tier automated tissue dissociation system with FFPE-to-nuclei processing without xylene, validated to 2 mg input and operating enzyme-free at 4°C for 6-10 minutes.

3Singulator 200+
CategoryTissue Dissociation Instrument
Description

High-capacity automated tissue dissociation system with FFPE-to-nuclei processing without xylene, enzyme-free operation at 4°C for 6-10 minutes, software-locked reproducibility across sites, and validated extraction of over 1 million nuclei from a single 50 µm FFPE curl in 40-60 minutes.

4Moxi V
CategoryCell Counting Instrument
Description

Coulter-principle impedance-based cell counter providing NIST-traceable volumetric cell counting and sizing at less than 2% CV, with natural debris exclusion, cassette-based zero-maintenance operation, and results in 8 seconds.

5Moxi Z
CategoryCell Counting Instrument
Description

Coulter-principle impedance-based cell counter with NIST-traceable precision at less than 2% CV, volumetric debris exclusion, cassette-based zero-maintenance operation, and results delivered in 8 seconds.

6Moxi GO II
CategoryFluorescence Cell Counter
Description

Benchtop cell counter combining Coulter-principle impedance counting with two-color fluorescence (488nm laser and dual PMTs) for viability, GFP, apoptosis, and immunophenotyping assays, with under 10-second processing, zero fluidics, native 21 CFR Part 11 compliance, FCS 3.1 export, and FlowJo compatibility.

7Velocyt
CategoryCell-Based Workflow Instrument
Description

Precision instrument for cell-based workflows, listed as a distinct product category in ORFLO's product navigation alongside the Singulator and Moxi families.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Maker of CellDrop, an image-based cell counter without consumables that competes on convenience rather than impedance-based precision. Targets overlapping academic/research customer base as an alternative to Moxi V/Z.

TypeDirect peer
Description

Sells the Countess and Invitrogen line of automated cell counters plus a broad cell therapy/single-cell workflow portfolio. Competes on price-bundling and global reach rather than differentiated precision.

TypeDirect peer
Description

Maker of gentleMACS tissue dissociators — the head-to-head competitor explicitly benchmarked in ORFLO's peer-reviewed glioblastoma study. Overlapping customer base in translational research and cell therapy.

TypeDirect peer
Description

Established manufacturer of cell counting and sizing instruments (Vi-CELL, Multisizer) based on Coulter principle. Most direct comp on Moxi with broader flow cytometry and life sciences portfolio and vastly larger commercial footprint.

TypeDirect peer
Description

Specialist in NucleoCounter line of cell counters and the Via1-Casette consumable architecture — directly analogous in cassette-based, precise counting approach to Moxi with strong adoption in cell/gene therapy QC.

TypeDirect peer
Description

Producer of the TC20 automated cell counter, a direct competitor to Moxi V/Z in routine lab cell counting. Brings significant brand reach and bundled reagent/flow-cytometry portfolio to academic and biotech customers.

TypeBroad incumbent
Description

Owns ProteinSimple, R&D Systems and ExoDx; competing in single-cell/prep reagents and analytical tools used alongside or instead of ORFLO's workflow in translational and pharma research.

TypeBroad incumbent
Description

Hematology and cell counting giant (XE-5000, pocH-100i) whose precision cell-counting capability competes with Moxi in clinical and translational labs. Brings deep installed base and IVD/clinical distribution.

TypeBroad incumbent
Description

Bioprocessing and cell-line development platform that touches upstream cell counting and single-cell analysis workflows. Adjacent competitor for cell-therapy and pharma process development customers.

10Levitas Bio
TypeEmerging player
Description

Emerging single-cell workflow company (LeviCell) in upstream sample prep. Competes with Singulator for tissue-dissociation and rare-cell workflows in translational research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ORFLO Technologies

Life Sciences Instrumentationorflo.com

ORFLO Technologies (Precision Cell Systems, Inc.) is a privately-held life sciences instrumentation company that develops automated tissue dissociation systems (Singulator) and Coulter-principle cell counters (Moxi) serving genomics labs, cell therapy programs, pharmaceutical manufacturers, and flow cytometry core facilities worldwide.

What ORFLO Technologies does

ORFLO Technologies, operating as Precision Cell Systems, Inc., is a privately-held life sciences instrumentation company founded in 2010 and headquartered in Livermore, California (with a listed address in Ketchum, Idaho). The company develops precision laboratory instruments for upstream cell-based workflows, serving genomics laboratories, translational oncology and cell therapy programs (including CAR-T QC), pharmaceutical and contract research organizations, and flow cytometry core facilities. As of the input, the company has 1,000+ instruments installed globally across 700+ institutions, with 200+ peer-reviewed publications citing its technology, and headcount in the 11-50 band.

The product portfolio centers on two complementary platforms: the Singulator family of automated tissue dissociation systems (Singulator 100, Singulator 200, and Singulator 200+) which convert fresh, frozen, or FFPE tissue into sequencing-ready cells or nuclei via software-locked, cold-temperature (4°C), enzyme-free protocols in 6-10 minutes; and the Moxi family of Coulter-principle impedance-based cell counters (Moxi V, Moxi Z for counting and sizing; Moxi GO II for counting combined with two-color fluorescence). The core technology is Coulter-principle impedance measurement, delivering NIST-traceable volumetric cell counting at <2% coefficient of variation with natural debris exclusion — substantially more precise than image-based alternatives (20-30% CV). The Moxi GO II adds 488nm laser fluorescence with dual PMTs and native 21 CFR Part 11 compliance for regulated environments.

The business model combines capital equipment sales (Singulator and Moxi instruments, quote-based pricing via "Request a Quote" and "Talk to a Specialist"), recurring revenue from disposable cassettes and consumables, and supporting application-scientist consultation services (notably a 20-minute workflow evaluation offering). Go-to-market is sales-led, targeting enterprise buyers through direct sales supported by content marketing, peer-reviewed validation assets, a resource library, webinars (Eventbrite, GenomeWeb, GoToWebinar, Zoom), conference engagement, and an e-commerce store for mid-market consumables access. Total disclosed funding to date is approximately $1.36M across two rounds (2013 and 2017), indicating a capital-efficient, largely revenue-funded operating posture. Compliance footprint includes 21 CFR Part 11 on the Moxi GO II, GDPR, and CCPA.

ORFLO Technologies firmographics

Firmographics
Name
ORFLO Technologies
Legal name
Precision Cell Systems, Inc.
Website
https://orflo.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
ORFLO Technologies (Precision Cell Systems, Inc.) is a privately-held life sciences instrumentation company that develops automated tissue dissociation systems (Singulator) and Coulter-principle cell counters (Moxi) serving genomics labs, cell therapy programs, pharmaceutical manufacturers, and flow cytometry core facilities worldwide.
Ownership category
akta.pro rank

ORFLO Technologies industry classification

Industry
Product category
Life Sciences Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)

Keywords

  • Cell counting instruments
  • Tissue dissociation systems
  • Flow cytometry analyzers
  • Single-cell genomics tools
  • Cell analysis instruments

Where ORFLO Technologies is headquartered

Location

Headquarters

HQ city
Ketchum
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ORFLO Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Precision Instruments (Capital Equipment): Sale of automated tissue dissociation systems (Singulator) and cell counters (Moxi family). Instruments include Singulator 100, Singulator 200, Singulator 200+, Moxi V, Moxi Z, and Moxi GO II.
  2. Disposable Consumables: Cassette-based system uses disposable cassettes for cell counting. Consumables provide recurring revenue stream and zero-maintenance operation model.
  3. Professional Services/Application Support: Application scientist consultations for workflow evaluation, offering 20-minute sessions to assess workflow, tissue types, and relevant validation data.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

ORFLO Technologies product offering

Product offering

Core offering

ORFLO Technologies (doing business as Precision Cell Systems) develops and manufactures precision laboratory instruments for cell-based workflows, primarily automated tissue dissociation systems (Singulator family) and Coulter-principle impedance-based cell counters (Moxi family, including fluorescence-capable Moxi GO II). Products are sold to genomics, translational oncology, cell therapy, pharma, and CRO laboratories, supported by disposable cassettes for recurring consumable revenue.

Product overview

ORFLO Technologies (Precision Cell Systems) offers a suite of precision laboratory instruments for cell-based workflows comprising the Singulator family for automated tissue dissociation and the Moxi family for Coulter-principle cell counting. The Singulator product line includes Singulator 100, Singulator 200, and Singulator 200+ models, providing automated conversion of fresh, frozen, or FFPE tissue to sequencing-ready cells with cold-temperature, software-locked processing. The Moxi product line encompasses Moxi V and Moxi Z (impedance-based Coulter-principle cell counters) and Moxi GO II (combining Coulter-principle counting with two-color fluorescence phenotyping). These instruments are designed as upstream precision solutions feeding sequencers and cytometers in genomics, translational oncology, and regulated manufacturing environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Singulator 100 Entry-level automated tissue dissociation system with software-locked reproducibility for converting fresh, frozen, and FFPE tissue samples to sequencing-ready cells using cold-temperature, enzyme-free processing.
  • Singulator 200 Mid-tier automated tissue dissociation system with FFPE-to-nuclei processing without xylene, validated to 2 mg input and operating enzyme-free at 4°C for 6-10 minutes.
  • Singulator 200+ High-capacity automated tissue dissociation system with FFPE-to-nuclei processing without xylene, enzyme-free operation at 4°C for 6-10 minutes, software-locked reproducibility across sites, and validated extraction of over 1 million nuclei from a single 50 µm FFPE curl in 40-60 minutes.
  • Moxi V Coulter-principle impedance-based cell counter providing NIST-traceable volumetric cell counting and sizing at less than 2% CV, with natural debris exclusion, cassette-based zero-maintenance operation, and results in 8 seconds.
  • Moxi Z Coulter-principle impedance-based cell counter with NIST-traceable precision at less than 2% CV, volumetric debris exclusion, cassette-based zero-maintenance operation, and results delivered in 8 seconds.
  • Moxi GO II Benchtop cell counter combining Coulter-principle impedance counting with two-color fluorescence (488nm laser and dual PMTs) for viability, GFP, apoptosis, and immunophenotyping assays, with under 10-second processing, zero fluidics, native 21 CFR Part 11 compliance, FCS 3.1 export, and FlowJo compatibility.
  • Velocyt Precision instrument for cell-based workflows, listed as a distinct product category in ORFLO's product navigation alongside the Singulator and Moxi families.

Quantifiable outcome

  • 10x more viable cells recovered (96% viability) vs. gentleMACS in peer-reviewed glioblastoma study
  • +5 more outcomes

Companies that use ORFLO Technologies

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

ORFLO Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

ORFLO Technologies partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves4 records

Expansion highlights5 records

ORFLO Technologies competitors and assessment

Company assessment

Emerging players

  • DeNovix: Maker of CellDrop, an image-based cell counter without consumables that competes on convenience rather than impedance-based precision. Targets overlapping academic/research customer base as an alternative to Moxi V/Z.
  • Levitas Bio: Emerging single-cell workflow company (LeviCell) in upstream sample prep. Competes with Singulator for tissue-dissociation and rare-cell workflows in translational research.

Direct peers

  • Thermo Fisher Scientific: Sells the Countess and Invitrogen line of automated cell counters plus a broad cell therapy/single-cell workflow portfolio. Competes on price-bundling and global reach rather than differentiated precision.
  • Miltenyi Biotec: Maker of gentleMACS tissue dissociators — the head-to-head competitor explicitly benchmarked in ORFLO's peer-reviewed glioblastoma study. Overlapping customer base in translational research and cell therapy.
  • Beckman Coulter Life Sciences: Established manufacturer of cell counting and sizing instruments (Vi-CELL, Multisizer) based on Coulter principle. Most direct comp on Moxi with broader flow cytometry and life sciences portfolio and vastly larger commercial footprint.
  • Chemometec: Specialist in NucleoCounter line of cell counters and the Via1-Casette consumable architecture — directly analogous in cassette-based, precise counting approach to Moxi with strong adoption in cell/gene therapy QC.
  • Bio-Rad Laboratories: Producer of the TC20 automated cell counter, a direct competitor to Moxi V/Z in routine lab cell counting. Brings significant brand reach and bundled reagent/flow-cytometry portfolio to academic and biotech customers.

Broad incumbents

  • Bio-Techne: Owns ProteinSimple, R&D Systems and ExoDx; competing in single-cell/prep reagents and analytical tools used alongside or instead of ORFLO's workflow in translational and pharma research.
  • Sysmex: Hematology and cell counting giant (XE-5000, pocH-100i) whose precision cell-counting capability competes with Moxi in clinical and translational labs. Brings deep installed base and IVD/clinical distribution.
  • Sartorius: Bioprocessing and cell-line development platform that touches upstream cell counting and single-cell analysis workflows. Adjacent competitor for cell-therapy and pharma process development customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

ORFLO Technologies social profiles

Digital presence

ORFLO Technologies compliance and trust

Trust signal

Compliance3 records

ORFLO Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ORFLO Technologies leadership team

Management profile

Number of profiles

Profiles3 records

ORFLO Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ORFLO Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ORFLO Technologies

What does ORFLO Technologies do?

ORFLO Technologies (doing business as Precision Cell Systems) develops and manufactures precision laboratory instruments for cell-based workflows, primarily automated tissue dissociation systems (Singulator family) and Coulter-principle impedance-based cell counters (Moxi family, including fluorescence-capable Moxi GO II). Products are sold to genomics, translational oncology, cell therapy, pharma, and CRO laboratories, supported by disposable cassettes for recurring consumable revenue.

Is ORFLO Technologies a public or private company?

ORFLO Technologies is a private company. It is classified as unknown and is currently operating.

When was ORFLO Technologies founded?

ORFLO Technologies was founded in 2010. It employs 1 to 10 people.

Where is ORFLO Technologies based?

ORFLO Technologies is headquartered in Ketchum, United States, in the North America region.

How does ORFLO Technologies make money?

Three revenue lines are on record. Precision Instruments (Capital Equipment) is the primary driver. The others are disposable Consumables and professional Services/Application Support.

Who are ORFLO Technologies's main competitors?

Emerging players on record are DeNovix and Levitas Bio. Direct peers are Thermo Fisher Scientific, Miltenyi Biotec, Beckman Coulter Life Sciences, Chemometec and Bio-Rad Laboratories. Broad incumbents are Bio-Techne, Sysmex and Sartorius.

Does ORFLO Technologies have an API?

No public API is recorded for ORFLO Technologies.

What industry is ORFLO Technologies in?

ORFLO Technologies's product category is Life Sciences Instrumentation. Its primary akta.pro industry code is HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations), with a secondary code of HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals